United Kingdom· GB-APID-19736611000001107
Cilest 35microgram/250microgram tablets
A medicinal product containing ethinylestradiol + norgestimate, registered in United Kingdom by Mawdsley-Brooks & Company Ltd.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Ethinylestradiol + Norgestimate
- Manufacturer
- Mawdsley-Brooks & Company Ltd
- Country
- United Kingdom (GB)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Ethinylestradiol + norgestimate in 10 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FranceFEMI, compriméEFFIK
- CanadaTRI-CIRA 21APOTEX INC
- PolandElinZakłady Farmaceutyczne POLPHARMA S.A.
- FinlandCilestJanssen-Cilag Oy
- SpainEDELSIN comprimidosJanssen-Cilag
- SwitzerlandLiberelle, FilmtablettenExeltis Suisse SA
- GermanyAmicetteAristo Pharma Gmbh (Art 57)
- IrelandCilique 250/35 microgram tabletsGedeon Richter Plc
Authorised across Europe · EMA
The same active substance is authorised in 12 EEA countries. Names it is sold under:
- Belgium · Cibel
- Germany · Amicette, Lysandra
- Denmark · Amorina, Liberelle
- Spain · Edelsine
- France · Femi, Naravela
- Ireland · Cilique
- Italy · Briladona, Briladona Trifase
- Netherlands · Norgestimaat/Ethinylestradiol Xiromed
- Norway · Amorina
- Poland · Elin, Liberelle
- Portugal · Etinilestradiol + Norgestimato Leon Farma, Femi
- Sweden · Amorina
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/8e8db9fc-af75-4e8d-a729-8af4b80f8f97 GET /v1/drugs/8e8db9fc-af75-4e8d-a729-8af4b80f8f97?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "19736611000001107",
"desc": "Cilest 35microgram/250microgram tablets (Mawdsley-Brooks & Company Ltd)",
"form": "Oral tablet",
"vpid": "41877611000001100",
"source": "dmd",
"vtm_id": "775869004",
"strength": "35 microgram",
"substance": "Ethinylestradiol + Norgestimate",
"ingredient": "Ethinylestradiol",
"supplier_code": "15125811000001100"
}See everything about ethinylestradiol + norgestimate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.